Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogeny Exploration and Treatment Optimization for Refractory Vitiligo
ChiCTR-IPR-16009964Phase 4Not yet recruiting
- Sponsor
- Shanghai Skin Disease Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of minocycline and simvastatin in Vitiligo (4 arms), sponsored by Shanghai Skin Disease Hospital. Primary endpoint: Lesion size. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
minocyclinesimvastatin
03
Conditions
Vitiligo
Beyond the preview
Go deeper on ChiCTR-IPR-16009964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009964.